Interaction between clopidogrel and proton pump inhibitors [2]

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 12, 2009, Pages 1228-1229

  Allen, Michael J ^a   McLean Veysey, Pamela ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Capital Health Halifax   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PANTOPRAZOLE; PROTON PUMP INHIBITOR; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ACUTE HEART INFARCTION; HEART REINFARCTION; HUMAN; LETTER; CASE CONTROL STUDY; DRUG COMBINATION; DRUG INTERACTION; HEART INFARCTION; NOTE; RECURRENT DISEASE; RISK; RISK ASSESSMENT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; CASE-CONTROL STUDIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PROTON PUMP INHIBITORS; RECURRENCE; RISK ASSESSMENT; TICLOPIDINE;

EID: 67649177403     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1090017     Document Type: Letter

References (2)

1. Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009;180:713-8.
2. Breslow NE, Day NE. Statistical methods in cancer research: Vol. I. The analysis of case-control studies. IARC Scientific Publications no. 32. Lyon (France): International Agency of Research on Cancer; 1980.